Clinical trial
Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial
NCT06466330 is registered in ClinicalTrials.gov with Societe Francaise de Rhumatologie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial
- Lead sponsor
- Societe Francaise de Rhumatologie
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 10, 2025
- Completion date
- February 28, 2027
- Enrollment
- 112 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
knee pain chronic, knee pain swelling